Aldosterone-receptor antagonism and end-stage renal disease.
about
Disordered aldosterone-volume relationship in end-stage kidney disease.Aldosterone and mortality in hemodialysis patients: role of volume overload.Eplerenone: the evidence for its place in the treatment of heart failure after myocardial infarctionTherapeutic efficacy of renin-angiotensin blockade in patients receiving dialysis.Safety and cardiovascular effects of mineralocorticoid receptor antagonists for patients receiving hemodialysis: a systematic review and meta-analysis.
P2860
Aldosterone-receptor antagonism and end-stage renal disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Aldosterone-receptor antagonism and end-stage renal disease.
@en
Aldosterone-receptor antagonism and end-stage renal disease.
@nl
type
label
Aldosterone-receptor antagonism and end-stage renal disease.
@en
Aldosterone-receptor antagonism and end-stage renal disease.
@nl
prefLabel
Aldosterone-receptor antagonism and end-stage renal disease.
@en
Aldosterone-receptor antagonism and end-stage renal disease.
@nl
P2093
P2860
P1476
Aldosterone-receptor antagonism and end-stage renal disease.
@en
P2093
Domenic A Sica
Niall McLaughlin
Todd W B Gehr
P2860
P2888
P304
P356
10.1007/S11906-004-0029-1
P577
2004-08-01T00:00:00Z